Latest / Bloomberg Intelligence
OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.
See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.